Mr Michael Grant
Chief Executive Officer
Michael has over 25 years’ experience in pharmaceutical and biotech development and commercial management functions. Underpinned with science qualifications and a solid background in research and development, Michael has had commercial roles at Australian, Western European and Global levels including 10 years with global biotech CSL. As Senior Director, Commercial Development for CSL’s Coagulation and Acquired Bleeding portfolios, Michael worked with R&D and Commercial functions to manage the strategic direction of CSL’s leading products and recombinant pipeline.
Michael brings this extensive experience to the commercialization of Q-Sera’s market changing technology.